Metraipolis › archive › dc_f6d250dd90ff
Albumin Nanoparticles in Cancer Therapeutics: Clinical Status, Challenges, and Future Directions — Europe PMC PMID:41155927
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41155927
- DOI
- 10.3390/pharmaceutics17101290
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T14:50:50.112Z
- SHA-256 of the archived text
3069f5f8f12fe139569ab9f423ae7b9f91f8e4257750f8f5357a5e1c0253ce5c- Stable URL of this page
https://metraipolis.com/documento/dc_f6d250dd90ff
How to cite
Albumin Nanoparticles in Cancer Therapeutics: Clinical Status, Challenges, and Future Directions — Europe PMC PMID:41155927 — Europe PMC (en), https://europepmc.org/article/MED/41155927 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f6d250dd90ff (Metraipolis archive dc_f6d250dd90ff, sha256 3069f5f8f12fe139569ab9f423ae7b9f91f8e4257750f8f5357a5e1c0253ce5c)
BibTeX
@misc{dcf6d250dd90ff,
title = {Albumin Nanoparticles in Cancer Therapeutics: Clinical Status, Challenges, and Future Directions — Europe PMC PMID:41155927},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41155927},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f6d250dd90ff; sha256 3069f5f8f12fe139569ab9f423ae7b9f91f8e4257750f8f5357a5e1c0253ce5c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155927. Agents can read the archived copy with the MCP tool read_document.